Skip to main content
. Author manuscript; available in PMC: 2024 Nov 4.
Published in final edited form as: Best Pract Res Clin Rheumatol. 2024 Jun 19;38(2):101964. doi: 10.1016/j.berh.2024.101964

Table 1.

CARD9 associations in axial spondyloarthritis.

Reference CARD9 SNP Main findings
[20] rs10781499 Increased comorbidity rates due to pleiotropy not heterogeneity (axSpA, Crohn’s disease, Ps, primary sclerosing cholangitis, and ulcerative colitis).
[10] rs4077515 and rs3812571 (tagged), rs11794847, rs10781505, rs10781499, rs3812570, rs3812571, rs10870149 Association between axSpA and IBD with CARD9; cis-acting effects on CARD9.
[21] rs10781500 CARD9 strongly associated with disease pathogenesis, may point to mechanism for HLA-B27; supports β-glucan induced disease (IL-23-IL23R-IL-17 pathway).
[22] rs11145763 Pediatric-age-of-onset autoimmune diseases.
[23] rs1128905 CARD9 SNP located at exon-intron boundaries, predicted to influence splicing.
[24] rs4077515, rs3812571 Chinese Han population shows minimal association between these CARD9 variants in axSpA, in contrast to European populations. Highlights importance of racial diversity in association studies.
[25] rs4077515 Iranian population: CARD9 associated with axSpA in HLA-B27-positive patients, but protective in HLA-B27-negative patients.